Flamingo Pharmaceuticals

Mumbai, India Founded: 1985 • Age: 41 yrs
Manufactures and distributes pharmaceutical products to over 50 countries worldwide.

About Flamingo Pharmaceuticals

Flamingo Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1985 by Ashwin Thacker. It manufactures and distributes pharmaceutical products to over 50 countries worldwide. It operates on a B2B model. The company has 552 employees. Its Indian entity Flamingo Pharmaceuticals Limited reported revenue of β‚Ή637 Cr. Flamingo Pharmaceuticals offers products and services including Pharmaceutical Products. Its focus areas include Pharmaceuticals, Manufacturing, Drug Production and R&D.

Company details

Flamingo Pharmaceuticals Ltd., founded in 1985, specializes in pharmaceutical manufacturing and RD. Based in Mumbai, India, it produces and supplies over 50 products across various therapeutical areas. The company operates globally, serving markets in more than 50 countries on all continents, with regulatory approvals like UK MHRA and US FDA. It focuses on quality compliance and innovation in drug production.

  • Headquarters Mumbai, India
  • Employees 552
  • Founders Ashwin Thacker
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website flamingopharma.com
  • Social LinkedIn
  • Legal Name Flamingo Pharmaceuticals Ltd
  • Date of Incorporation 12 Jun, 1985
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹637 Cr

    FY 2026 · +25% YoY

  • Net Profit
    ₹96.92 Cr

    FY 2026 · 15% margin

  • EBITDA
    ₹161 Cr

    FY 2026 · 25% margin

  • Employee Count
    552

Products & Services of Flamingo Pharmaceuticals

Flamingo Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products.

Pharmaceutical Products
Medications

Supplies various drugs for multiple therapeutical areas globally

Board of directors of Flamingo Pharmaceuticals Limited (Flamingo Pharmaceuticals)

Flamingo Pharmaceuticals Limited is the primary company behind Flamingo Pharmaceuticals. The board of Flamingo Pharmaceuticals Limited currently have 6 directors; the longest-serving is Ashwin Jethalal Thacker, appointed in 1986. 24 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ashwin Jethalal Thacker
DIN 00048595
Director23 Jun 198640 yrs 4 moFlamingo Pharmaceuticals Limited
Pranay Ashwin Thacker
DIN 03035833
Director08 Jun 20215 yrs 4 moFlamingo Pharmaceuticals Limited
Meena Sanjiv Kapadi
DIN 08074814
Director28 Sep 20224 yrsFlamingo Pharmaceuticals Limited
Chhotulal Rawa Bhagwat
DIN 03534822
Director25 Oct 20224 yrsFlamingo Pharmaceuticals Limited
Sunil Kumar
DIN 08202567
CEO02 Aug 20233 yrs 2 moFlamingo Pharmaceuticals Limited
Parth Ashwin Thacker
DIN 08202584
Director10 Nov 20232 yrs 11 moFlamingo Pharmaceuticals Limited

People of Flamingo Pharmaceuticals

9 people are tracked at Flamingo Pharmaceuticals (7 in leadership, 2 in team); the tracked headcount is 552.

NameRoleGroup
Founder, Chairman, MDLeadership
Sunil Mahajan
Chief Executive OfficerLeadership
Seema Vaidya
Head Corporate QualityLeadership
Patrick Storey
Head Of Business DevelopmentLeadership
Shanthi Iyer
General Manager CommercialLeadership
Balasubramanian Nagarajan
Head Corporate QualityLeadership
Vaishali Vaidya
Head HrLeadership
Akash Gurav
Officer Corporate Quality AssuranceTeam
Sachin Gotwal
Sales ExecutiveTeam
Premium access

Complete people profiles for Flamingo Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Flamingo Pharmaceuticals

Figures of Flamingo Pharmaceuticals Limited, the primary company behind Flamingo Pharmaceuticals, for FY 2026. Revenue was ₹637 Cr (+25% year on year). Net profit was ₹96.92 Cr (15% margin). EBITDA was ₹161 Cr (25% margin). Revenue has grown at a compounded annual rate of +25% over three years and +21% over five years.

  • ₹637 CrRevenue · FY 2026 · +25% YoY
  • ₹96.92 CrNet profit · 15% margin
  • ₹161 CrEBITDA · 25% margin
  • ₹6.80 CrPaid-up capital
  • 552Employees (provident fund records)
  • +25%Revenue CAGR, 3 years
  • +21%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Flamingo Pharmaceuticals Limited are on its company page.

Premium access

Detailed financial statements for Flamingo Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Flamingo Pharmaceuticals

The website of Flamingo Pharmaceuticals (flamingopharma.com) receives about 1.3K visits a month and ranks #8,817,391 among all websites worldwide, #7,500 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    1.3K

    ▼ 19.7% vs previous month

  • Global rank
    #8,817,391

    among all websites

  • Category rank
    #7,500

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Flamingo Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
maneeshpharma.com
95%
1.1K#8,101,116View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Flamingo Pharmaceuticals

Flamingo Pharmaceuticals was founded in 1985.

Flamingo Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Flamingo Pharmaceuticals has 552 employees.

The primary company behind Flamingo Pharmaceuticals, Flamingo Pharmaceuticals Limited, reported revenue of β‚Ή637 Cr for FY 2026, up 25% year on year.

Flamingo Pharmaceuticals Ltd., founded in 1985, specializes in pharmaceutical manufacturing and RD. Based in Mumbai, India, it produces and supplies over 50 products across various therapeutical areas. The company operates globally, serving markets in more than 50 countries on all continents, with regulatory approvals like UK MHRA and US FDA. It focuses on quality compliance and innovation in drug production.

Flamingo Pharmaceuticals offers Pharmaceutical Products.

Flamingo Pharmaceuticals operates through Flamingo Pharmaceuticals Limited.

The legal entities of Flamingo Pharmaceuticals currently have 8 directors, including Sunil Kumar, Sukrut Jagdish Shah, Parth Ashwin Thacker and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available